InvestorsHub Logo
Followers 829
Posts 119591
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 663

Thursday, 07/16/2020 11:07:38 PM

Thursday, July 16, 2020 11:07:38 PM

Post# of 803
ABT 2Q20 Results by Business Segment


%Corp YoY Growth
Segment Sales (const currency)

Medical devices* 33% -20%
Diagnostics 27% +7%
Nutrition 26% +3%
Drugs† 14% -1%

COVID-19 testing boosted the diagnostics segment, while the cessation of elective surgical procedures clipped the medical-devices segment.

64% of overall sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News